Parakeet Health
AI platform automating patient access workflows for healthcare providers, converting patient demand into revenue.
Website: https://parakeethealth.com/
Cover Block
From the public record
| Field | Value |
|---|---|
| Name | Parakeet Health |
| Tagline | AI platform automating patient access workflows for healthcare providers, converting patient demand into revenue [Parakeet Health] |
| Headquarters | San Francisco, United States [Parakeet Health] |
| Founded | 2023 [PR Newswire, October 2024] |
| Stage | Series A [Morningstar/PR Newswire, October 2026] |
| Business model | SaaS |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | North America |
| Growth profile | Venture Scale |
| Founding team | Co-Founders (3+): Jung Park, Eric Mao, Aaron Lee [PR Newswire, October 2024] |
| Funding label | $10M+ |
| Total disclosed funding | ~$13,000,000 [Morningstar/PR Newswire, October 2026] |
Links
From the public record
- Website: https://parakeethealth.com/
- Careers: https://parakeethealth.com/careers
- Founding Technical Recruiter: https://jobs.canvas.vc/companies/parakeet-health/jobs/80540003-founding-technical-recruiter
- Tech Lead: https://app.dover.com/apply/parakeet-health/62d2b649-8059-40f5-b362-1276bd006718
The Short Version
PUBLIC Parakeet Health builds AI software for healthcare providers that automates patient access work, and it merits attention now because the company has moved from launch to a $10 million Series A while reporting meaningful adoption in a narrow, high-friction wedge of outpatient care [PR Newswire, October 2024] [Morningstar/PR Newswire, October 2026]. Founded in 2023 in San Francisco, the company is positioning itself around a familiar operational problem, missed calls, scheduling friction, referral leakage, and insurance questions that sit directly between patient demand and provider revenue, with early emphasis on dermatology and other multi-site specialties [Parakeet Health] [PR Newswire, September 2026].
The product case is straightforward: Parakeet says its platform handles inbound and outbound workflows across voice, SMS, email, web scheduling, and fax, with EMR integrations that support booking, eligibility checks, outreach, and follow-up, and the notable commercial wrinkle is outcome-tied pricing rather than pure seat-based software billing [Parakeet Health] [MedCity News, October 2024] [Parakeet Health, Why Parakeet Health]. That model could prove differentiated if it holds up in practice, because buyers in provider settings tend to care less about AI novelty than about whether the system reliably converts access volume into completed appointments and recovered revenue [HIT Consultant, October 2026] [Parakeet Health, FAQ].
The founding bench reads stronger than many early healthtech workflow companies. CEO Jung Park previously held executive roles at One Medical and Epocrates, co-founder and CPO Eric Mao previously led product and engineering teams at Microsoft and Primer AI, and CTO Aaron Lee previously led engineering teams at Rippling and Twitter [Parakeet Health, About] [PR Newswire, October 2024] [Parakeet Health, Meet Parakeet Health].
Capital formation has also been orderly. Parakeet announced a $3 million seed round led by Canvas Ventures in October 2024, then a $10 million Series A, also led by Canvas, in October 2026, bringing total disclosed funding to $13 million; the company sells on a SaaS basis, even if parts of pricing are framed as pay for performance [PR Newswire, October 2024] [Morningstar/PR Newswire, October 2026] [Citybiz, October 2026].
The next 12 to 18 months will likely turn on two public questions. First, whether dermatology-led traction, including the claim that Parakeet works with six of the 10 largest U.S. dermatology groups and supports more than 2,800 providers across 1,100-plus locations, broadens into durable multi-specialty adoption; second, whether company-reported growth signals such as 10x ARR expansion translate into evidence of repeatable enterprise deployment rather than strong early concentration in one buying motion [Morningstar/PR Newswire, October 2026] [Dover].
Single-source, plausible -- Relies on independent coverage from PR Newswire, MedCity News, and Citybiz, with several product and team details still sourced partly from company materials.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Series A |
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding | $13,000,000 disclosed |
The Company in Brief
PUBLIC
Parakeet Health emerged in San Francisco in 2023 with a narrow enough thesis to be legible and a broad enough product ambition to matter: automate the administrative work that sits between a patient seeking care and a provider getting that patient onto the schedule [Parakeet Health]. The company describes itself as an AI platform for patient access workflows, spanning communications and follow-up tasks that often sit across front-desk staff, call centers, and practice-management systems [Parakeet Health].
The public record on formation is still thin, but the core facts are consistent across the company’s own materials. Parakeet names Jung Park, Eric Mao, and Aaron Lee as founders, and places its operating base in San Francisco [Parakeet Health, October 2024] [Parakeet Health, Unknown].
The early timeline is straightforward. The company was founded in 2023, introduced itself publicly in October 2024 alongside a $3 million seed round, and by its own account had already positioned the product around healthcare voice AI and patient engagement workflows at launch [Parakeet Health] [Parakeet Health, October 2024]. Its careers materials and later company pages suggest a business still in buildout mode rather than one presenting as fully scaled, which is consistent with a venture-backed company less than three years from founding [Parakeet Health] [Parakeet Health, Unknown].
Unconfirmed -- This section relies primarily on company website materials, with partial corroboration from the company’s October 2024 launch announcement.
What They Have Built
Mixed sourcing
Parakeet Health is selling into a part of healthcare operations where scope matters more than novelty. Public materials consistently describe the product as an AI platform for patient access, with automation spanning inbound and outbound communications rather than a single scheduling widget or call-center overlay [Parakeet Health] [Parakeet Health, October 2024]. Across the company website and launch materials, the system is described as handling voice, SMS, email, web scheduling, and fax, with workflows including appointment booking, insurance verification, patient outreach, follow-up, rescheduling, cancellations, and referral intake [Parakeet Health] [Parakeet Health, October 2024] [Parakeet Health, FAQ]. MedCity News reported that the platform integrates with electronic medical record systems to support real-time booking, insurance eligibility checks, intake, and patient context retrieval, which is a more consequential claim than a generic "AI receptionist" label because it suggests workflow execution inside provider systems rather than simple front-end triage [MedCity News, October 2026] [MedCity News, October 2024].
The more recent public description is that Parakeet unifies five communication modalities, inbound voice, outbound outreach, digital fax, two-way SMS, and direct web scheduling, into a single patient-access workflow layer [HIT Consultant, October 2026]. That framing is broadly consistent with third-party descriptions from investors and employees on LinkedIn, but those references are better read as directional corroboration than hard product verification [LinkedIn, Charlie Wood, retrieved 2026] [LinkedIn, Adam Messinger, retrieved 2026]. Commercially, the unusual point is the company's stated pay-for-performance pricing model, tied to outcomes such as appointments booked, interactions resolved, and revenue generated, according to its website [Parakeet Health, Why Parakeet Health]. If that structure is used in practice at scale, it could reduce procurement friction for provider groups, but the public record here still leans heavily on company framing rather than independent implementation detail.
A few operating signals round out the picture without proving more than they should. A published case study says one regional primary care group used the platform to handle and route 98% of patient calls, though that metric remains company-supplied and should be treated accordingly [Parakeet Health, Case Study]. Two public job postings, for a Founding Technical Recruiter and a Tech Lead in San Francisco, suggest the company is still building core technical and organizational capacity (inferred from job postings), which fits an early enterprise software team expanding after initial go-to-market traction [Canvas Ventures Jobs] [Dover].
Single-source, plausible -- Product scope is corroborated across company materials and named press coverage, but several capability and outcome claims remain company-supplied or only partially corroborated.
Market Size and Demand
PUBLIC
The market matters now because outpatient providers are under pressure to convert rising patient demand into scheduled, reimbursable visits without adding equivalent front-desk labor, and Parakeet is selling directly into that operational gap [MedCity News, October 2026] [PR Newswire, October 2024].
Public evidence does not support a clean TAM, SAM, and SOM build for Parakeet's exact category, so the more defensible approach is to frame the company against adjacent markets that are explicitly cited. The company describes itself as automating patient-access workflows across voice, SMS, email, web scheduling, and fax for health systems, multi-site practices, and specialty-care groups [Parakeet Health] [Parakeet Health, Unknown]. Third-party coverage also places the product in the electronic medical-record-connected patient engagement and conversational AI workflow layer, rather than a narrow call-center software niche [MedCity News, October 2026].
What the public record does show is where demand is already concentrating. At launch in October 2024, Parakeet named Galileo, Genome Medical, and Medical Dermatology and Cosmetic Surgery as customers [PR Newswire, October 2024]. By September 2026, a Dover job listing described the company as supporting more than 400 medical practices across 27 specialties [Dover]. By October 2026, the company said it worked with six of the 10 largest U.S. dermatology groups and supported more than 2,800 providers across 1,100-plus locations [Morningstar/PR Newswire, October 2026]. That sequence suggests the immediate serviceable market is enterprise outpatient care, with dermatology emerging as the first repeatable wedge rather than the ceiling of the business [PR Newswire, September 2026] [Morningstar/PR Newswire, October 2026].
The main tailwinds are operational complexity and channel fragmentation. The product claims consistently center on appointment booking, insurance verification, follow-up, referrals, billing inquiries, cancellations, and proactive outreach across voice, fax, SMS, and web scheduling [Parakeet Health] [HIT Consultant, November 2025] [HIT Consultant, October 2026]. Those are not cosmetic features. They map to revenue-cycle-adjacent tasks that become harder as provider groups expand across sites and specialties, and they help explain why Parakeet's disclosed traction skews toward large dermatology networks and multi-location care organizations [PR Newswire, November 2025] [PR Newswire, September 2026].
A small set of public operating figures gives a rough segmentation view, even if it is company-supplied.
| Cited market signal | Figure | Date | Source |
|---|---|---|---|
| Medical practices supported | 400+ | September 2026 | [Dover] |
| Specialties served | 27 | September 2026 | [Dover] |
| Providers supported | 2,800+ | October 2026 | [Morningstar/PR Newswire, October 2026] |
| Locations supported | 1,100+ | October 2026 | [Morningstar/PR Newswire, October 2026] |
| Largest U.S. dermatology groups served | 6 of 10 | October 2026 | [Morningstar/PR Newswire, October 2026] |
The picture here is narrower than a whole-healthcare software market and more interesting than a single-point scheduling tool. Public traction points to a multi-site outpatient operations market where scale, specialty complexity, and patient access friction are the practical segmentation variables.
Adjacent and substitute markets matter because Parakeet is not selling into an empty category. Its workflow surface overlaps with patient engagement software, contact-center infrastructure, digital front door products, scheduling tools, referral management, and portions of revenue cycle operations [MedCity News, October 2026] [Parakeet Health] [HIT Consultant, October 2026]. The substitute is often not another AI-native vendor alone, but a patchwork of call centers, outsourced answering services, EMR modules, web schedulers, and manual staff workflows. That broadens the addressable budget pool, but it also means the company must prove replacement value across several incumbent systems rather than just outperforming one direct category peer.
Regulatory and macro forces cut both ways. On the supportive side, healthcare providers have longstanding incentives to reduce administrative burden, improve appointment throughput, and capture revenue tied to completed visits and downstream care [MedCity News, October 2026] [PR Newswire, September 2026]. On the constraining side, Parakeet operates in patient communications and scheduling workflows that touch protected health information and require dependable integration with EMR systems, so enterprise adoption will tend to favor vendors that can show compliance readiness, workflow reliability, and measurable ROI rather than consumer-style growth alone [MedCity News, October 2024] [MedCity News, October 2026]. The company's public pricing language, which ties fees to appointments booked, interactions resolved, and revenue generated, also indicates a market that is being asked to buy on outcomes, not only on software seats [Parakeet Health, Unknown].
Inferred, not confirmed -- Market sizing for Parakeet's exact category is not independently disclosed in the provided sources, and the section relies heavily on company and company-amplified traction claims, with partial corroboration from MedCity News and job-listing evidence.
Who Else Is Fighting for This
MIXED
Parakeet Health is positioning itself less as a general communications layer and more as a workflow system for patient access, which puts it in competition not only with specialty-specific operators such as Animal Dermatology Group [PUBLIC] [Animal Dermatology Group] but also with broader patient-engagement and scheduling stacks that already sit near the front desk, the call center, or the electronic medical record [PUBLIC] [MedCity News, October 2026] [Parakeet Health].
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| Parakeet Health | AI platform for patient access workflows across voice, SMS, email, web scheduling, and fax for healthcare providers | Series A, total disclosed funding of about $13M | Multi-modal workflow automation tied to outcomes such as appointments booked, interactions resolved, and revenue generated | [Morningstar/PR Newswire, October 2026] [Parakeet Health] |
| Animal Dermatology Group | Veterinary dermatology practice network | Not cited in provided research | Specialty care operator rather than software vendor, relevant mainly as a domain-specific care delivery alternative in dermatology workflows | [Animal Dermatology Group] |
The competitive map is fragmented because the buying problem itself is fragmented. Incumbents sit inside the record system, practice-management stack, and outsourced contact-center model, where buyers already have budget and established process [PUBLIC] [MedCity News, October 2026]. Challengers such as Parakeet are trying to replace manual scheduling, referral follow-up, billing inquiry handling, and cancellation backfill with AI-driven automation across multiple channels, while adjacent substitutes include staffing-heavy service models and point products that cover only one modality such as voice or SMS [PUBLIC] [HIT Consultant, October 2026] [PR Newswire, October 2024].
Parakeet's clearest edge today appears to be focus. Public materials consistently describe direct EMR integration, real-time booking, insurance-related workflows, and a five-modality communications stack, which is a more operationally specific pitch than a generic healthcare chatbot [PUBLIC] [MedCity News, October 2024] [HIT Consultant, October 2026]. The company also appears to have found an early distribution wedge in dermatology, with announced relationships spanning Schweiger Dermatology, Aegis Medical Group, and QualDerm, and a company claim that it works with six of the 10 largest U.S. dermatology groups by October 2026 [PUBLIC] [PR Newswire, November 2025] [PR Newswire, September 2026] [Morningstar/PR Newswire, October 2026]. That said, this edge looks perishable unless it compounds into proprietary workflow data, deeper integrations, or multi-year enterprise entrenchment, because channel automation itself is unlikely to remain scarce capital or scarce talent over the next 18 months [PUBLIC] [Morningstar/PR Newswire, October 2026] [MedCity News, October 2026].
The main exposure is that Parakeet does not own the system of record or the underlying patient relationship. If an incumbent EMR vendor, practice-management vendor, or a better-capitalized patient-engagement platform can offer similar scheduling, outreach, and intake automation natively, Parakeet risks being evaluated as an add-on rather than control-plane software [PUBLIC] [MedCity News, October 2026] [Parakeet Health]. Animal Dermatology Group is not a direct software rival on the evidence provided, but it illustrates a different constraint: specialty operators with strong internal process control can decide to solve patient access with in-house operational redesign, reducing the opening for third-party software in some care settings [PUBLIC] [Animal Dermatology Group].
The most plausible 18-month scenario is continued share capture in specialty outpatient groups where missed calls, referral leakage, and rescheduling friction are measurable enough to support pay-for-performance pricing [PUBLIC] [Parakeet Health, Why Parakeet Health] [PR Newswire, September 2026]. In that scenario, Parakeet is the likely winner if dermatology and adjacent specialties keep buying best-of-breed workflow automation before their core vendors close product gaps [PUBLIC] [Morningstar/PR Newswire, October 2026]. The more likely loser if EMR-linked incumbents compress the feature gap quickly is any independent point solution whose differentiation rests mainly on automating communications channels rather than owning deeper workflow, data, or reimbursement logic, and on the public record Parakeet has not yet shown that those deeper moats are fully established [PUBLIC] [MedCity News, October 2026] [Parakeet Health].
Opportunity
PUBLIC
The prize here is unusually large for a workflow company because patient access sits close to revenue, retention, and capacity utilization for providers, and Parakeet Health has already shown early signs that it can sell into scaled outpatient organizations rather than only small practices [Morningstar/PR Newswire, October 2026] [PR Newswire, September 2026].
The headline opportunity is straightforward: Parakeet could become the operating layer that sits between patient demand and provider capacity across ambulatory care. That is a bigger outcome than an AI call bot. The public evidence points to a platform that already spans voice, SMS, email, web scheduling, and fax, with workflows covering appointment booking, insurance verification, outreach, follow-up, referrals, and scheduling changes [Parakeet Health] [HIT Consultant, October 2026] [MedCity News, October 2026]. The reach is still early and some of the operating claims remain company-sourced, but the company has disclosed work with more than 2,800 providers across 1,100-plus locations and said it serves six of the 10 largest U.S. dermatology groups, which suggests this is at least being tested in enterprise-grade environments where the integration burden and workflow complexity are real [Morningstar/PR Newswire, October 2026].
The reason that outcome looks reachable, not merely aspirational, is that the company appears to have found a credible wedge. Dermatology is a sensible starting point because missed calls, cancellations, overdue follow-ups, and referral leakage directly affect booked visits and downstream procedure revenue, and Parakeet has public references from Schweiger Dermatology, Aegis Medical Group, and QualDerm Partners that place it inside that operating problem set [PR Newswire, November 2025] [PR Newswire, September 2026]. The additional signal is commercial packaging: Parakeet says it offers pay-for-performance pricing tied to appointments booked, interactions resolved, and revenue generated, which aligns product spend with provider economics in a category where software buyers often scrutinize ROI closely [Parakeet Health].
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Dermatology system of record for access | Parakeet becomes the default patient-access layer across large dermatology groups, then standardizes scheduling, follow-up, and referral recovery across that specialty | The QualDerm national collaboration and the claim of working with six of the 10 largest U.S. dermatology groups create category credibility [PR Newswire, September 2026] [Morningstar/PR Newswire, October 2026] | Dermatology already appears to be the company's strongest public beachhead, with named deployments and specialty-specific traction signals [PR Newswire, November 2025] [Morningstar/PR Newswire, October 2026] |
| Multi-specialty ambulatory expansion | The company uses EMR integration and multi-channel workflows to move from dermatology into broader outpatient specialties and regional health systems | A platform that already covers inbound voice, outbound outreach, digital fax, SMS, and web scheduling can solve adjacent access problems without a new product category [HIT Consultant, October 2026] [MedCity News, October 2024] | A Dover job listing described support for 400-plus medical practices across 27 specialties, including primary care, dermatology, optometry, and mental health, which, while not independently verified, suggests cross-specialty applicability [Dover] |
| Revenue-share infrastructure for patient access | Parakeet becomes one of the few vendors in healthcare operations that is bought on measurable throughput and revenue outcomes rather than seats or licenses alone | Pay-for-performance pricing, if retained at scale, gives procurement and operators a clearer budget owner and ROI case [Parakeet Health] | The product is positioned around booked appointments, resolved interactions, and revenue generated, and a case study said one regional primary care group used the platform to handle and route 98 percent of patient calls, indicating buyers may accept outcome-linked automation when reliability is high [Parakeet Health, Case Study] |
If compounding takes hold, it likely starts with workflow breadth rather than a classic consumer network effect. Each new deployment gives Parakeet another large set of scheduling rules, referral pathways, insurance questions, cancellation patterns, and channel preferences to encode into product workflows, while EMR integrations make the software harder to replace once it is trusted for real-time booking and intake context [MedCity News, October 2024] [MedCity News, October 2026]. The company also appears to benefit from modality convergence: once a provider group uses the platform for voice, it can add SMS, fax, outreach, and direct web scheduling inside the same patient-access stack, which should raise contract value and deepen operational dependency over time [HIT Consultant, October 2026] [Parakeet Health].
There is an early hint that this compounding may already be underway. Public materials describe the platform as unifying five communication modalities, and the company said annual recurring revenue increased 10x in the year preceding the Series A while provider and location counts expanded materially [HIT Consultant, October 2026] [Morningstar/PR Newswire, October 2026]. The revenue figure is company-reported and should be treated cautiously, but paired with named enterprise customers and partnerships, it supports the view that one successful access workflow can open adjacent ones inside the same account [PR Newswire, October 2024] [PR Newswire, November 2025] [PR Newswire, September 2026].
The size of the win depends on whether Parakeet remains a specialty access vendor or becomes broader ambulatory infrastructure. No credible public market cap or acquisition comparable was provided in the source set, so precision would overstate what the evidence can support. Still, if the "multi-specialty ambulatory expansion" scenario plays out and the company becomes embedded infrastructure for scheduling, referral recovery, and patient communications across large outpatient groups, the outcome could reasonably support a venture-scale enterprise value in the hundreds of millions of dollars (scenario, not a forecast), because the company would sit on a revenue-critical workflow with direct ties to appointment conversion and provider utilization [MedCity News, October 2026] [Morningstar/PR Newswire, October 2026]. What makes that upside worth underwriting is not generic AI enthusiasm, but the narrower fact pattern that Parakeet is already selling a cross-channel product into scaled provider environments where access failures are visible in lost visits and lost revenue [PR Newswire, November 2025] [PR Newswire, September 2026].
Single-source, plausible -- This section relies on a mix of independent coverage and company-originated disclosures, with key traction metrics and pricing details supported primarily by PR distribution, company materials, or job-listing language rather than broad third-party corroboration.
Sources
From the public record
[Parakeet Health] AI Patient Access Platform | Convert Patient Demand Into Revenue | Parakeet Health | https://parakeethealth.com/
[PR Newswire, October 2024] Parakeet Health Launches With Generative AI Voice Platform to Transform Patient Engagement for Healthcare Providers | https://www.prnewswire.com/news-releases/parakeet-health-launches-with-generative-ai-voice-platform-to-transform-patient-engagement-for-healthcare-providers-302275698.html
[Morningstar/PR Newswire, October 2026] Parakeet Health Raises $10 Million Series A Following 10x Growth and Rapid Enterprise Adoption | https://www.morningstar.com/news/pr-newswire/20261001sf61267/parakeet-health-raises-10-million-series-a-following-10x-growth-and-rapid-enterprise-adoption
[MedCity News, October 2026] Parakeet Health Secures $10M for Conversational/Agentic Platform | https://medcitynews.com/2026/10/parakeet-health-secures-10m-for-conversational-agentic-platform/
[Citybiz, October 2026] Parakeet Health raises 10 million Series A to expand healthcare AI platform | https://www.citybiz.co/article/912784/parakeet-health-raises-10-million-series-a-to-expand-healthcare-ai-platform/
[PR Newswire, September 2026] QualDerm and Parakeet Health Partner to Expand Patient Access Across National Dermatology Network | https://www.prnewswire.com/news-releases/qualderm-and-parakeet-health-partner-to-expand-patient-access-across-national-dermatology-network-302870711.html
[Parakeet Health] Why Parakeet Health | Healthcare-Native Voice AI with Pay-for-Performance | https://parakeethealth.com/why-us
[Parakeet Health] FAQ: AI Voice Agents for Healthcare Scheduling | Parakeet Health | https://parakeethealth.com/faqs
[Parakeet Health] About Parakeet Health | Healthcare Operators + AI Engineers Building Voice AI | https://parakeethealth.com/about
[Parakeet Health] Meet Parakeet Health | https://parakeethealth.com/blog/meet-parakeet-health
[Dover] Tech Lead | https://app.dover.com/apply/parakeet-health/62d2b649-8059-40f5-b362-1276bd006718
[Canvas Ventures Jobs] Founding Technical Recruiter | https://jobs.canvas.vc/companies/parakeet-health/jobs/80540003-founding-technical-recruiter
[PR Newswire, November 2025] Schweiger Dermatology and Aegis Medical Group Transform Patient Engagement With Generative AI Platform from Parakeet Health | https://www.prnewswire.com/news-releases/schweiger-dermatology-and-aegis-medical-group-transform-patient-engagement-with-generative-ai-platform-from-parakeet-health-302619406.html
Articles about Parakeet Health
- Parakeet Health's AI Agents Already Book Appointments for 2,800 Providers — The startup, which just raised a $10 million Series A, is automating patient access for six of the largest U.S. dermatology groups.